Haemostatic problems in liver disease.
作者信息
Kelly D A, Tuddenham E G
出版信息
Gut. 1986 Mar;27(3):339-49. doi: 10.1136/gut.27.3.339.
Abstract
摘要
相似文献
1
Haemostatic problems in liver disease.肝病中的止血问题。
Gut. 1986 Mar;27(3):339-49. doi: 10.1136/gut.27.3.339.
2
Protective role of metallothionein in coagulatory disturbance accompanied by acute liver injury induced by LPS/D-GalN.金属硫蛋白在脂多糖/ D-半乳糖胺诱导的急性肝损伤伴发的凝血紊乱中的保护作用
Thromb Haemost. 2008 May;99(5):980-3. doi: 10.1160/TH07-10-0637.
3
Blood clotting abnormalities in liver disease.肝病中的凝血异常。
Prog Liver Dis. 1976;5:350-62.
4
Significance of intravascular coagulation and fibrinolysis in acute hepatic failure.血管内凝血和纤维蛋白溶解在急性肝衰竭中的意义。
Scand J Gastroenterol Suppl. 1973;19:133-4.
5
[Blood coagulation disorders in liver diseases].
Rev Invest Clin. 1975 Apr-Jun;27(2):159-68.
6
Hemostatic problems in liver surgery.肝脏手术中的止血问题。
Scand J Gastroenterol Suppl. 1973;19:71-81.
7
Intravascular coagulation in liver disease.肝病中的血管内凝血。
Annu Rev Med. 1974;25:447-55. doi: 10.1146/annurev.me.25.020174.002311.
8
The role of the liver in biosynthesis of the non-vitamin K-dependent clotting factors.肝脏在非维生素K依赖凝血因子生物合成中的作用。
Semin Thromb Hemost. 1977 Summer;4(1):15-28. doi: 10.1055/s-0028-1087125.
9
Fasting (acute energy deprivation) in man: effect on blood coagulation and fibrinolysis.人体禁食（急性能量剥夺）：对血液凝固和纤维蛋白溶解的影响。
Am J Clin Nutr. 1977 Dec;30(12):1963-7. doi: 10.1093/ajcn/30.12.1963.
引用本文的文献
1
The Provocative Roles of Platelets in Liver Disease and Cancer.血小板在肝脏疾病和癌症中的激发作用。
Front Oncol. 2021 Jul 21;11:643815. doi: 10.3389/fonc.2021.643815. eCollection 2021.
2
Disseminated intravascular coagulation: new identity as endotheliopathy-associated vascular microthrombotic disease based on in vivo hemostasis and endothelial molecular pathogenesis.弥散性血管内凝血：基于体内止血和内皮分子发病机制的与内皮病变相关的血管微血栓形成疾病新认识
Thromb J. 2020 Oct 14;18:25. doi: 10.1186/s12959-020-00231-0. eCollection 2020.
3
Tonsillar Kaposi Sarcoma in an HIV-Negative Patient: A Case Report.一名HIV阴性患者的扁桃体卡波西肉瘤：病例报告
Turk Arch Otorhinolaryngol. 2019 Mar;57(1):46-49. doi: 10.5152/tao.2018.3487. Epub 2019 Feb 28.
4
Fibrinogen alpha C chain 5.9 kDa fragment (FIC5.9), a biomarker for various pathological conditions, is produced in post-blood collection by fibrinolysis and coagulation factors.纤维蛋白原α C链5.9 kDa片段（FIC5.9）是多种病理状况的生物标志物，在采血后由纤溶和凝血因子产生。
Clin Proteomics. 2016 Oct 7;13:27. doi: 10.1186/s12014-016-9129-6. eCollection 2016.
5
Acquired coagulant factor VIII deficiency induced by Bacillus anthracis lethal toxin in mice.炭疽芽孢杆菌致死毒素诱导小鼠获得性凝血因子VIII缺乏症。
Virulence. 2015;6(5):466-75. doi: 10.1080/21505594.2015.1031454. Epub 2015 Apr 23.
6
Renal and Gastrointestinal Considerations in Joint Replacement Surgery.关节置换手术中的肾脏和胃肠道考量
J Nat Sci. 2015 Feb 1;1(2):e46.
7
Evaluation of initial heparin infusion rates for a high-dose protocol.高剂量方案初始肝素输注速率的评估。
J Thromb Thrombolysis. 2014 May;37(4):419-26. doi: 10.1007/s11239-013-0963-3.
8
Expression of LYVE-1 in sinusoidal endothelium is reduced in chronically inflamed human livers.LYVE-1 在慢性炎症的人类肝脏中的窦状内皮细胞中的表达减少。
J Gastroenterol. 2010 Mar;45(3):317-25. doi: 10.1007/s00535-009-0152-5. Epub 2009 Nov 12.
9
Coagulopathy in liver disease.肝病中的凝血功能障碍。
Curr Treat Options Gastroenterol. 2007 Dec;10(6):464-73. doi: 10.1007/s11938-007-0046-7.
10
New insights into the coagulopathy of liver disease and liver transplantation.肝病及肝移植凝血障碍的新见解
World J Gastroenterol. 2006 Dec 28;12(48):7725-36. doi: 10.3748/wjg.v12.i48.7725.
本文引用的文献
1
STUDIES ON PROCONVERTIN (FACTOR VII).V. BIOSYNTHESIS IN SUSPENSION CULTURES OF RAT LIVER CELLS.凝血酶原转变加速因子（因子VII）的研究。V. 大鼠肝细胞悬浮培养中的生物合成
Scand J Clin Lab Invest. 1964;16:540-8. doi: 10.3109/00365516409060552.
2
PROTHROMBIN SYNTHESIS IN THE DOG.狗体内凝血酶原的合成
Am J Physiol. 1964 May;206:929-38. doi: 10.1152/ajplegacy.1964.206.5.929.
3
THE CELLULAR LOCALIZATION OF FIBRINOGEN AS REVEALED BY THE FLUORESCENT ANTIBODY TECHNIQUE.
Vox Sang. 1963 Jul-Aug;8:461-73. doi: 10.1111/j.1423-0410.1963.tb04169.x.
4
Study of acquired dysfibrinogenaemia in liver disease.肝病中获得性异常纤维蛋白原血症的研究。
Thromb Res. 1980;19(1-2):29-41. doi: 10.1016/0049-3848(80)90401-6.
5
Disseminated intravascular coagulation in hepatic failure treated with antithrombin III.应用抗凝血酶III治疗肝衰竭中的弥散性血管内凝血
Thromb Res. 1981;22(5-6):701-4. doi: 10.1016/0049-3848(81)90070-0.
6
Hypercoagulability in acute esophageal variceal bleeding.急性食管静脉曲张出血中的高凝状态。
Thromb Res. 1981 May 1;22(3):243-51. doi: 10.1016/0049-3848(81)90116-x.
7
Bleeding after liver biopsy does not correlate with indices of peripheral coagulation.肝活检后的出血与外周凝血指标无关。
Dig Dis Sci. 1981 May;26(5):388-93. doi: 10.1007/BF01313579.
8
Platelet lipid composition and platelet aggregation in human liver disease.人类肝脏疾病中的血小板脂质组成与血小板聚集
J Lipid Res. 1981 Mar;22(3):423-30.
9
Platelet associated immunoglobulins on chronic liver disease.慢性肝病中的血小板相关免疫球蛋白
Br J Haematol. 1981 Jun;48(2):347-50.
10
Platelet-associated IgG in acute and chronic hepatic diseases.急慢性肝病中的血小板相关免疫球蛋白
Scand J Haematol. 1980 Nov;25(5):417-22. doi: 10.1111/j.1600-0609.1981.tb01423.x.
Zotero 插件